Insight
Written by Vladimir Murovec, Head of Life Sciences Regulatory, Osborne Clarke in Brussels The pharma and medtech sectors have a strategic window to implement AI literacy ahead of an August enforcement deadline The EU Artificial Intelligence (AI) Act, since becoming law on 1 August 2024, has been progressively introducing a phased implementation of regulatory deadlines that have set [...]
By the McDermott Will & Emery team The volume of private equity exit activity has taken a tumble since the heady days of 2021, with sponsors choosing to hold onto assets longer in the face of tight M&A markets. For the last few years, a material difference between the price sellers want for their assets [...]
Type 1 diabetes is a chronic condition, in which the immune system mistakenly attacks and destroys the insulin-producing cells in the pancreas - the beta (β)cells, leading to little or no insulin production. For patients, this requires a lifetime commitment to careful monitoring and control blood sugar levels, making it a challenging medical condition that [...]
By Lisa Farrell, business development manager at the National Robotarium The NHS stands at a critical crossroads. With productivity levels still lagging 16% behind pre-pandemic figures and over 31,000 nursing positions unfilled across England alone, our healthcare system faces unprecedented challenges. Yet within this crisis lies an opportunity for transformation through strategic deployment of robotics [...]
A UK neurosurgeon and NHS "clinical entrepreneur" who is developing a lower cost alternative to mixed reality surgical planning and training tools has been backed by investors. XARlabs, founded by Dr. Ali Haddad and based in London, has closed a US$2.3m seed funding round to help grow its "high-precision mixed reality" technology that can be [...]
By Valerie Armstrong-Surgenor, Partner within MFMac’s Healthcare & Life Sciences team The EU's product liability framework will be updated soon, following the publishing of Directive (EU) 2024/2853, and member states must implement its provisions by December 2026. Importantly, this will create divergence from UK product liability law under the Consumer Protection Act 1987 (based on [...]
Flow is an alternative treatment for depression which is being trialled by the NHS and is already available from more than 100 clinics. Flow uses a non-invasive brain stimulation technique - transcranial direct current stimulation (tDCS) - to target the left dorsolateral prefrontal cortex, which is the area of the brain controlling key cognitive skills [...]
Angela Maragna is a transformation and change leader with expertise in driving digital innovation, co-director of One HealthTech, and a member of the HETT Steering Committee. Here, she shares her excitement about HETT North in Manchester and tells visitors about the many agenda sessions, features, and networking opportunities they can expect. Angela Maragna didn’t begin [...]
By EatMoreFruit Communications In the ever-evolving healthcare media landscape, Digital PR bridges the traditional benefits of reach, share of voice, and sentiment with the power of Search Engine Optimization (SEO)—delivering both meaningful connections and measurable outcomes. By blending PR strategies with SEO-driven link-building and domain authority, it’s a holistic approach designed to amplify your impact. [...]
By McDermott Will & Emery Investors continue to flock to pharma services, targeting opportunities across the range of providers to the biopharmaceutical industry that can cover everything from preclinical development and clinical trials to manufacturing, distribution and commercialisation. According to Pitchbook data, there were 774 private equity deals in pharma services in the three years [...]
